NSCMID 2026 Meeting Scientific Programme

 

Copenhagen Denmark

Thursday / 27 August 2026.

12:15-12:25 Opening of NSCMID 2026, Mette Damkjær Bartels, meeting president.

12:25-13:55 Session 1

From Prescribing to Perception: Antibiotic Access, Stewardship in primary care and Public Knowledge.
Chairs: Sebastian von Huth (DEN, ID) and Valtýr Stefánsson Thors (IS, PID).

Lecture 1 Antimicrobial Stewardship in general practice: Experiences from the Nordics, Malene Plejdrup Hansen (DEN).

Lecture 2 Access to antibiotics: Hurdles and Solutions, Christine Årdal (NO).

Lecture 3 What does the public in Iceland know about antibiotic use and AMR? Results of an electronic survey and lessons learned, Anna Margrét Halldórsdóttir (IS).

13:55-14:25 Exhibition and Coffee

14:25-15:55 Session 2

Updates in the Management of Implant Associated Infections.                                                                                                 Chairs: Nis Pedersen Jørgensen (DEN, ID) and Magnus Rasmussen (SWE, ID).

Lecture 1 Phage therapy in France: Real-world experience from patients treated for implant-associated infections, Tristan Ferry (FRA).

Lecture 2 Management of VGEI in the Scandinavian setting, Oskar Ljungquist (SWE).

Lecture 3 Foreign body infections of the heart: Recents advances and ongoing research, Emil Fosbøl (DEN).

15:55-16:30 Exhibition and Coffee

16:30-17:00 Industry Symposium - Shionogi 

CIRCE real-world insights: what is the role of cefiderocol in the evolving CRE-MBL landscape?

Lecture 1 A brief introduction to the Nordic CPE- landscape, Arnfinn Sundsfjord (NOR).

Lecture 2 Presentation of the CIRCE study data, José María Aguado (ES).

17:00-17:50 Honorary Lecture

Chair: Mette Damkjær Bartels (DEN, CM)

From Bench to Breakpoints: A Journey in Antifungal Susceptibility, Maiken Cavling Arendrup (DEN)

19:00-21:00 Welcome reception at Statens Serum Institute (SSI)

 

Friday / 28 August 2026 

09:00-10:00 Session 3

Syndromic Testing: Balancing Clinical Value and Cost Efficiency.                                                                                                       Chairs: Mette Damkjær Bartels (DEN, CM) and Antti Hakanen (FIN, CM).

Lecture 1 The clinical impact of Meningitis/encephalitis syndromic panel, Xiaohui Nielsen (DEN).

Lecture 2 Multiplex PCR panels for blood cultures – does it have a place in the Nordic Countries? Jukka Torvikoski (FIN).

10:00-10:30 Exhibition and Coffee

10:30-11:30 Poster session and poster walks 

11:30-12:30 Industry Symposium - Pfizer

Tick-Borne Diseases in the Nordics: Long-Term Sequelae, Diagnostic Challenges, and Prevention.
Chair: Andreas Palmborg (SWE).

Lecture 1 Overview of neurological, cognitive, and functional outcomes after TBE, recovery patterns over time, and factors associated with incomplete recovery,              Hilde Kristin Skudal (NOR).

Lecture 2 Diagnostic considerations in Lyme disease and neuroborreliosis, epidemiological trends, and current evidence on long-term health and functional outcomes, Anna Maria Florescu (DEN).

Lecture 3 Epidemiology of TBE in a highly endemic region and the impact of a general vaccination program based on population-level data, Jessica Tikkala (FIN).

12:30-13:30 Lunch

13:30-15:00 Session 4

Modulating the microbiome: future perspectives, beyond C.diff.
Chairs: Ulrik Stenz Justesen (DEN, CM) and Maria Rubin (DEN, CM).

Lecture 1 Rebalancing Immunity through the Gut: FMT in Autoimmune and Chronic Inflammatory Diseases, Maja Skov Kragsnæs (DEN).

Lecture 2 “Oncobiome”: The role of the microbiome in cancer development and treatment, Lars Engstrand (SWE).

Lecture 3 Microbiota therapies: What does the future hold? Christian Lodberg Hvas (DEN).

15:00-15:30 Exhibition and Coffee

15:30-17:00 Session 5

Infections in immunosuppressed.                                                                                                                                                       Chairs: Daria Podlekareva (DEN, ID) and Valtýr Stefánsson Thors (IS, PID).

Lecture 1 Infections in immunosuppressed patients: Overview of challenges and strategies for prevention, Christian Fischer (DEN).

Lecture 2 Infections in the immunocompromised host: Clinical cases and the role of the ID doctor, Søren Jensen-Fangel (DEN).

Lecture 3 Vaccination challenges in patients with secondary immunodeficiency, Zitta Harboe (DEN).

17:00-17:30 Exhibition and Coffee

17:30-18:30 Session 6

CNS infections.
Chairs: Ulrik Stenz Justesen (DEN, CM) and Truls Legaard (NO, CM).

Lecture 1 CNS infections in Danish Children and Adolescents in the 2020 era: Trends and insights, Ulrikka Nygaard (DEN).

Lecture 2 Clinical Experience with Routine Next-Generation Sequencing of Cerebrospinal Fluid Samples, Else Quist-Paulsen (NO).

 

Saturday / 29 August 2026 

08:30-09:00 NSCMID general assembly (members only)

09:00-10:30 Session 7

HIV cure, PrEP/doxy-PEP and targeted Chlamydia screening.
Chairs: Rikke Krogh Madsen (DEN, ID) and Annika Ljung (SWE, CM).

Lecture 1 HIV cure, Ole Schmeltz Søgaard (DEN).

Lecture 2 PrEP and Doxy-PEP: Experiences from a Nordic Antibiotic Stewardship Perspective, Finn Filén (SWE).

Lecture 3 Targeted Chlamydia screening in the Netherlands: Considerations and implementation, Zoïe Alexiou (NL).

10:30-11:00 Exhibition and Coffee

11:00-12:00 Session 8

When AMR gets worst: carbapenemase producing Enterobacterales.
Chairs: Barbara Holzknecht (DEN, CM) and Antti Hakanen (FIN, CM).

Lecture 1 CPE-epidemiology in the Nordics: same same but different, Arnfinn Sundsfjord (NO).

Lecture 2 Lessons learned from the management of CPE-outbreaks, Anne Line Engsbro (DEN).

12:00-12:30 Session 9

Late Breaker.
Chairs: Barbara Holzknecht (DEN, CM) and Antti Hakanen (FIN, CM).

Lecture Saving the Central Venous Catheter: A Randomized Trial of Hydrochloric Acid Lock Therapy, Mette Bondø Mønster (DEN).

12:30-13:30 Lunch

13:30-14:45 Session 10

Early career session. 
Chairs: Nis Pedersen Jørgensen (DEN, ID) and Magnus Rasmussen (SWE, ID).

Lecture 1 The Effects of Infant Antibiotic Exposure on Microbiome Composition and Vaccine Responses, Birta Baeringsdottir (IS).

Lecture 2 Risk of acute kidney injury after empirical gentamicin treatment in patients with suspected sepsis, Siri Nordtveit (NO).

Lecture 3 Plasma level of soluble urokinase-type plasminogen activator receptor (suPAR) predicts severe disease in Streptococcus dysgalactiae subsp. equisimilis bacteremia, Miia Saukkosaari (FIN).

Lecture 4 Host-pathogen interactions shape persistence in Staphylococcus aureus bacteremia: a machine learning approach in a population-based cohort, Pernilla Kihlberg (SWE).

Lecture 5 Faecal microbiota transplantation for decolonisation of multidrug resistant organisms in adult gastrointestinal carriers – a randomised clinical trial, Maja Johanne Søndergaard Knudsen (DEN).

14:45-15:00 Exhibition and Coffee

15:00-16:00 Poster session and poster walks 

16:00-17:00 Session 11

Fungal infections.
Chairs: Daria Podlekareva (DEN, ID) and Lena Rós Ásmundsdóttir (IS, CM).

Lecture 1 New and old drugs for treatment of mould infections, Jannik Helweg-Larsen (DEN).

Lecture 2 Invasive Candida infections – in the Nordic countries, Ingvild Nordøy (NO).

19:30-23:30 Conference dinner at Aamaans (Refshaleøen)

 

Sunday / 30 August 2026

09:00-10:30 Session 12

S. aureus bacteremia.                                                                                                                                                                       Chairs: Kim Thomsen (DEN, CM) and Asko Järvinen (FIN, ID).

Lecture 1 Refining β-Lactam Therapy for MSSA Bacteremia: Insights from Recent Comparative Trials, Achim Kaasch (GER).

Lecture 2 Penicillin-susceptibility in S. aureus: testing, epidemiology and clinical implications, Malin Hagstrand Aldman (SWE).

Lecture 3 Complicated or uncomplicated SAB - what do we really know about deep infection foci occurrence? Erik Forsblom (FIN).

10:30-11:00 Exhibition and Coffee

11:00-13:00 Session 13

Hot Topics.
Chairs: Barbara Holzknecht (DEN, CM) and Truls Legaard (NO, CM).

Lecture 1 Epidemiological and clinical clues from a recent Listeria outbreak, Carl Spindler (SWE).

Lecture 2 From Overcaution to Evidence: Reducing Unnecessary Penicillin Allergy Labels, Simo Sirkeoja (FIN). 

Lecture 3 Avian flu - the next human pandemic? Ramona Trebbien (DEN).

Lecture 4 RSV Prevention Strategies in Infancy: Efficacy of Long-Acting Monoclonal Antibodies and Maternal Vaccines, Terho Heikkinen (FIN).

13:00-13:10 Closing remarks and welcome to NSCMID2027

Mette Damkjær Bartels and Lena Rós Ásmundsdóttir

13:10 Lunch - Grab & Go